Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss

Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales New Studies Show that FenuLife Lowers Blood Sugar Levels New Studies Show that FenuLife Lowers Blood Sugar Levels New Studies Show that FenuLife Lowers Blood Sugar Levels Emerging Research Reveals Important Role of Chromium Picolinate in Insulin Resistance and Chronic Disease Emerging Research Reveals Important Role of Chromium Picolinate in Insulin Resistance and Chronic Disease New Clinical Trial Adds to Body of Evidence Showing Chromium Picolinate Lowers Blood Sugar in Insulin-Treated People with Poorly-Controlled Type 2 Diabetes New Clinical Trial Adds to Body of Evidence Showing Chromium Picolinate Lowers Blood Sugar in Insulin-Treated People with Poorly-Controlled Type 2 Diabetes Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects. Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects. Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects. Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects. Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects. Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects. New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%. New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%. New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA. New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes. New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes. New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes. New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes Results of Clinical Trial Examining Effects of Diachrome on Atherogenic Index of Plasma Presented at 2nd International Symposium on Triglycerides and HDL New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes Results of Clinical Trial Examining Effects of Diachrome on Atherogenic Index of Plasma Presented at 2nd International Symposium on Triglycerides and HDL New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes Results of Clinical Trial Examining Effects of Diachrome on Atherogenic Index of Plasma Presented at 2nd International Symposium on Triglycerides and HDL Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women. Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	PROVO, Utah, June 2, 2005 /PRNewswire-FirstCall via COMTEX/ -- Pharmanex, a Nu Skin Enterprises (NUS) company, announced today a study that found Tegreen 97(R) to provide blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects -- a precursor to type-2 diabetes. The findings of the new study were recently presented at the American Heart Association's Sixth Annual Conference in Washington, D.C. "We are honored by the American Heart Association's invitation to present our newest findings on Tegreen 97," said Joe Chang, Ph.D., president of Pharmanex. "The results of this study are very meaningful in building a greater body of knowledge related to two significant health issues today: weight gain and lack of blood sugar control. We have shown with this and other studies that Tegreen 97 can have a significant beneficial effect in managing these two health conditions." Tegreen 97(R) is a proprietary, decaffeinated green tea extract standardized to 97 percent polyphenols -- two-thirds of which are catechins, the element responsible for the observed effect. Each capsule of Tegreen 97(R) contains the same amount of catechins as seven cups of the traditionally brewed green tea drink. About the Study The purpose of this study was to examine the effects of Tegreen 97(R) in enhancing insulin sensitivity and improving glucose-lipid metabolism. In addition, the research examined the effects of the proprietary green tea supplement in lowering body weight and weight of abdominal fat and inhibiting angiogenesis, which is the formation and differentiation of blood vessels, a key pathological process in the development of abnormal cells. Angiogenesis is hypothesized to play an important role in development of obesity. Following are the results of the study: * Tegreen 97(R) enhanced insulin sensitivity* * Improved glucose-lipid metabolism* * Increased fat burning and decreased body fat percentage* * Lowered body weight associated with inhibited angiogenesis.* "Our findings proved that in addition to its significance in protecting cells from abnormal mutation, inhibition of angiogenesis by Tegreen 97 is associated with reduction of body weight," said Josh Zhu, senior director of clinical R&D for Pharmanex and chief researcher of the study. "Tegreen 97 not only supports the general belief in the anti-aging benefits of tea catechins but may also provide benefits to people with Metabolic Syndrome X, overweight and those with subsequent cardiovascular and brain health concerns." Tegreen 97(R) is also included in LifePak(R), the company's comprehensive multivitamin/mineral and antioxidant supplement. Pharmanex Pharmanex, a Nu Skin Enterprises company, applies pharmaceutical processes and scientific measurement to create nutritional supplements for more than 40 markets worldwide. Pharmanex(R) products are sold direct to the consumer through the Internet and a network of independent distributors. For more information, go to www.pharmanex.com. The Company Nu Skin Enterprises, Inc. is a global direct selling company operating in 40 markets throughout Asia, the Americas and Europe. The company markets premium quality personal care products under the Nu Skin(R) brand, science-based nutritional supplements under the Pharmanex(R) brand, and technology based products and services under the Big Planet(R) brand. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS." *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software